Numerous reports have highlighted the contribution of MSH2 and MLH1 genomic deletions to hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch's syndrome, but genomic duplications of these genes have been rarely reported. Using quantitative multiplex PCR of short fluorescent fragments (QMPSF), 962 and 611 index cases were, respectively, screened for MSH2 and MLH1 genomic rearrangements. This allowed us to detect, in 11 families, seven MSH2 duplications affecting exons 1-2-3, exons 4-5-6, exon 7, exons 7-8, exons 9-10, exon 11, and exon 15, and three MLH1 duplications affecting exons 2-3, exon 4 and exons 6-7-8. All duplications were confirmed by an independent method. The contribution of genomic duplications of MSH2 and MLH1 to HNPCC can therefore be estimated approximately to 1% of the HNPCC cases. Although this frequency is much lower than that of genomic deletions, the presence of MSH2 or MLH1 genomic duplications should be considered in HNPCC families without detectable point mutations.
Introduction
Hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch's syndrome, which represents the most common form of inherited colorectal cancer, results from germline alterations of the DNA mismatch repair genes MSH2, MLH1, MSH6 and PMS2 (for review see Gruber 1 ). Identification of the causal alteration is essential for an appropriate clinical management of the families as it allows to offer to carriers an efficient tumour detection, based on colonoscopy and hysteroscopy every 2 years from 20 years of age and to avoid an inappropriate follow-up in noncarriers. 25 We now report the detection of 10 MSH2 and MLH1 exonic duplications, 7 of which are novel. The aim of this report was to highlight the contribution to HNPCC of MMR genomic duplications and to estimate the frequency of these alterations.
Materials and methods

Patients
Patients analysed in this study, either fulfilled Amsterdam (AMS) criteria (at least three relatives with colorectal cancer, cancer of the endometrium, small bowel, ureter or renal pelvis, one of whom is a first-degree relative of the other two; at least two successive generations affected; and at least one cancer diagnosed before age 50 26 ) or were selected because of a suggestive familial history associated to a microsatellite instability (MSI) phenotype in the tumour. A total of 962 and 611 index cases were, respectively, screened for MSH2 and MLH1 genomic rearrangements.
QMPSF analysis
The QMPSF protocol used to screen for genomic rearrangements of MSH2 and MLH1 has been described previously. 5, 6 Briefly, short fragments corresponding to the 16 MSH2 and 19 MLH1 exons and to control genes, were simultaneously PCR-amplified using dye-labeled primers. Primer sequences are available upon request. PCR products were separated by electrophoresis on an ABI-377 or 3100 automated sequencer (Applied Biosystems, Foster, USA). Data were analysed using the Gene Scanner Model 672 Fluorescent Fragment Analyzer (Applied Biosystems, Foster, USA). For each index case, QMPSF profile was superposed to that generated from a control-DNA by adjusting to the same level the peaks obtained for the control amplicon. Based on an extensive number of QMPSF analyses (including 450 genes and 41000 tests) performed in our laboratory, we have estimated the variability of gene copy number measurements to be 0.1 among control samples. Thus, copy number ratios between 0.9 and 1.1 indicate two gene copies, and copy number ratios between 1.4 and 1.6 indicate three copies. 
Results
Using QMPSF, we detected 10 distinct genomic duplications of MSH2 or MLH1 genes in 11 families: seven duplications involved MSH2 exons 1 -2 -3, exons 4 -5 -6, exon 7, exons 7 -8, exons 9 -10, exon 11, and exon 15, and three duplications involved MLH1 exons 2 -3, exon 4 and exons 6 -7 -8 ( Table 1) . As illustrated by Figure 1 , exonic duplications could easily be detected by QMPSF by a 1.5 increase of the corresponding peaks. Only the duplication of MSH2 exons 9 -10 detected in family L14 had previously been confirmed by long-range PCR. 5 MLPA was therefore used in the present study to confirm the nine other duplications. In each case, MLPA confirms the presence of the exonic duplication(s) detected by QMPSF. These duplications generate in MLPA an increase of the corresponding peak area(s) above 1.3. In one family (G1), we observed a discrepancy between QMPSF and MLPA concerning the extent of duplication. Indeed, QMPSF revealed the presence of a MSH2 duplication involving exons 5 -6, whereas MLPA suggested that this duplication also involved exon 4. In order to clarify the situation, we designed new QMPSF assays exploring specifically intron 3, exon 4 and intron 4 of MSH2. These complementary QMPSF analyses revealed that, within the G1 family, the duplication included exon 4, but did not extend to nucleotide c.646 -121 corresponding to the sense primer used in the first QMPSF assay, and therefore did not involve the first 1920 nucleotides of intron 3.
Discussion
One hypothesis that might explain the difference in the numbers of MMR genes genomic deletions and duplications reported so far is the technical difficulty to detect duplications versus deletions. Indeed, the largest series of HNPCC patients screened for MMR genomic rearrangements have been analysed using QMPSF 13 or MLPA. 19 In both methods, heterozygous deletions result in a 0.5 reduction of the corresponding peaks, whereas duplications generate a 1.5 increase. This could explain why duplications are more difficult to detect than deletions, and this might represent a technical bias in the estimation of MMR duplications frequency. QMPSF analysis allowed us in this large series of suspected HNPCC patients to detect 
